Neimeth International Pharmaceuticals Q2 2026 Board Meeting Outcome
Neimeth International Pharmaceuticals Plc has disclosed that its Board of Directors met on 24th July 2026 and approved the company's Unaudited Financial Statements for the second quarter ended 30th June 2026. The company has indicated the statements will be filed with the Nigerian Exchange Limited on or before 30th July 2026.
Neimeth International Pharmaceuticals Plc has notified the Nigerian Exchange Limited (NGX) and the investing public of the outcome of its Board of Directors' meeting held on Friday, 24th July 2026, in Lagos, Nigeria.
At the meeting, the Board approved the company's Unaudited Financial Statements for the second quarter (Q2) ended 30th June 2026. The company stated that these financial statements will be filed on or before 30th July 2026.
In connection with the upcoming release, Neimeth confirmed that the closed period previously announced for trading in the company's shares by insiders and connected persons remains in effect. The closed period will only be lifted twenty-four hours after the Q2 2026 Unaudited Financial Statements are officially released to the public.
The notice was signed by Chinenye S. Adekanmbi, the Company Secretary, and was dated 24th July 2026. No financial figures were disclosed in this filing, as the actual unaudited results are to be published separately ahead of the 30th July 2026 deadline.
